Planned phase III trial of SyB D-0701 for the prevention of nausea and vomiting following emetogenic chemotherapy
Phase of Trial: Phase III
Latest Information Update: 11 Aug 2006
At a glance
- Drugs Granisetron (Primary)
- Indications Chemotherapy-induced nausea and vomiting
- Focus Registrational; Therapeutic Use
- 11 Aug 2006 New trial record.